Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Ustekinumab biosimilar shows clinical similarity to reference drug for plaque psoriasis
19 Oct 2023
bởiAudrey Abella
A phase III study presented at EADV 2023 demonstrated the similarity between SB17, a human monoclonal antibody and proposed ustekinumab biosimilar, and reference ustekinumab for the treatment of moderate-to-severe plaque psoriasis.
19 Oct 2023

ARCADIA trials: A win for nemolizumab in atopic dermatitis
17 Oct 2023
bởiAudrey Abella
In the phase III ARCADIA 1 and 2 trials, the investigational, first-in-class interleukin-31-Rα antagonist nemolizumab delivered early, rapid, and sustained improvements in the core signs and symptoms of atopic dermatitis (AD) in patients with moderate-to-severe disease.
17 Oct 2023

Too much animal-based protein poses increased AD risk
28 Sep 2023
bởiJairia Dela Cruz
Frequent intake of high-protein foods in diets, especially those derived from animals, appears to be associated with an increased risk of atopic dermatitis (AD) and allergic sensitization to common house dust mites, according to a study.
28 Sep 2023





